Gemma M. Mulder

Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug

Esther Meijer, R. T. Gansevoort, Paul E. de Jong et al. · Nephrology Dialysis Transplantation · 2011 · 74 citations · Full text

Effects of the EGFR Inhibitor Erlotinib on Magnesium Handling

Henrik Dimke, Jenny van der Wijst, Todd Alexander et al. · Journal of the American Society of Nephrology · 2010 · 55 citations · Full text

Magnesium Handling, Trpm6 Current Density, Medicine +11

ADAM17 up-regulation in renal transplant dysfunction and non-transplant-related renal fibrosis

Gemma M. Mulder, Wynand B.W.H. Melenhorst, Johanna W.A.M. Celie et al. · Nephrology Dialysis Transplantation · 2011 · 34 citations · Full text

Epidermal Growth Factor Receptor Inhibitor PKI-166 Governs Cardiovascular Protection without Beneficial Effects on the Kidney in Hypertensive 5/6 Nephrectomized Rats

Nadir Ulu, Gemma M. Mulder, Peter Vavrinec et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 26 citations

Heparin binding epidermal growth factor in renal ischaemia/reperfusion injury

Gemma M. Mulder, Willemijn N. Nijboer, Marc A. Seelen et al. · The Journal of Pathology · 2010 · 20 citations · Full text

Epidermal Growth Factor, Immunology, Pathology +21